6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
ID: 36C77024Q0369Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/382dbc08b957400289293c1450944157/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    (913) 684-0140
    Kelley.Cunningham@va.gov
    Files
    Title
    Posted
    36C77024Q0369_1.docx
    The Department of Veterans Affairs (VA), through the Network Contracting Office 15, plans to procure Clofimehene Citrate tablets for delivery to the Lancaster CMOP facility in Texas. The presolicitation notice outlines the requirement for one pharmaceutical item, specifically 480 units of Clofimehene Citrate 50mg tablets, with a response deadline set for September 17, 2024. The procurement targets small businesses and emphasizes adherence to the Drug Supply Chain Security Act, requiring vendors to submit their state wholesale distributor licensure. Interested suppliers must submit their quotations via email and provide a signed solicitation cover page, a completed price schedule, their state license, and a Buy American Act certificate. This solicitation reflects the VA's ongoing commitment to ensuring a steady supply of pharmaceuticals to meet the needs of Veterans while supporting small business participation in federal contracting opportunities.
    36C77024Q0369.docx
    The document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs for pharmaceutical supplies for the Consolidated Mail Outpatient Pharmacy (CMOP). It details the solicitation number, effective date, and contact information for submission. The acquisition is open to various types of small businesses, including women-owned and service-disabled veteran-owned businesses. Key provisions include specific delivery requirements, invoicing processes, and adherence to Federal Acquisition Regulations. Suppliers must ensure pharmaceutical products comply with shipping regulations (e.g., USPS-capable) and must provide documentation for drug supply chain security compliance. The proposal mandates bar code labeling on products and requires specific National Drug Codes (NDCs). The document emphasizes the importance of quality assurance throughout the procurement process, outlining expectations for product availability, acceptance, and recall notifications. Additionally, it includes clauses that enforce compliance with federal laws related to small business participation and regulations governing government contracts. Overall, this RFP exemplifies the federal government’s commitment to maintaining rigorous standards in procurement while promoting small business involvement.
    S02_Pricing Schedule_Q0369.xlsx
    The CMOP Lancaster RFQ 3677024Q0369 solicits quotes for pharmaceuticals and medical surgical supplies, with a delivery timeline of 10 days after receipt of order. Vendors must submit required documents, including a signed SF1449 cover page, an excel quote spreadsheet, a valid State Wholesale Distributor License, and a Buy American Act (BAA) certificate. The deadline for submissions is September 17, 2024, at 3:00 PM Central Time. Each vendor is limited to one proposal, and if proposing alternate NDCs, they must note any quantity adjustments in their submissions. The requirement mandates that pharmaceutical products must have a minimum shelf life of one year upon delivery, and vendors should specify expiration dates in their comments. The main item listed is Clomiphene Citrate 50mg tablets in a quantity of 480, with detailed documentation on NDCs, manufacturer information, and pricing required. The solicitation underscores the importance of compliance with federal standards and ensures that suppliers can meet urgent government health needs while maintaining quality and safety in pharmaceutical provisioning.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0095 770-25-1-801-0132 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement for Ferrous Sulfate 324 mg EC Tablets, with a total quantity of 24,000 tablets to be delivered to multiple CMOP locations. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products be bar-coded according to industry standards, ensuring safety and traceability. This solicitation underscores the VA's commitment to providing quality pharmaceutical supplies for its healthcare services, with a submission deadline for quotes set for December 30, 2024, at 9:00 AM CST. Interested vendors must submit their proposals, including a signed SF1449, an Excel price schedule, and a state wholesale distributor license, to the primary contact, Michael W McAlhaney, at Michael.McAlhaney@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0099 770-25-1-801-0137 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate Pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP), under solicitation number 36C77025Q0099. The procurement requires multiple quantities of Fenofibrate 145MG 90CT, with specific delivery to various CMOP facilities across the United States, emphasizing compliance with the Buy American statute. This initiative is crucial for ensuring the availability of essential pharmaceuticals for veterans, reflecting the VA's commitment to providing timely medical supplies. Interested vendors must submit their proposals by December 30, 2024, at 09:00 AM CST, including a signed SF1449 cover page, a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Buy American certificate, with all submissions directed to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires compliance with current Good Manufacturing Practices (cGMP) and mandates a unique National Drug Code (NDC) for each product offered, ensuring adherence to FDA regulations and drug supply chain security measures. Interested contractors must submit their proposals by December 31, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov for further information.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    770-25-1-801-0134 -National CMOP ZINC OXIDE OINT
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Zinc Oxide Ointment as part of a contract with the National CMOP Office. Vendors are required to supply varying quantities of this pharmaceutical product, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act and FDA approval. The ointment will be delivered to multiple VA CMOP facilities, with a total requirement exceeding 5,000 units, and must be shipped within 10 days of order receipt. Interested vendors must submit their proposals by December 30, 2024, at 4:00 PM Central Standard Time, including necessary documentation such as a signed SF1449 form and a Buy American Act certificate. For further inquiries, vendors can contact Sarah Fry at sarah.fry2@va.gov or call 913-758-9935.